Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV‐1 gag in HIV‐1‐infected subjects stimulates broad functional CD4+ T cell responses
Ist Teil von
European journal of immunology, 2006-10, Vol.36 (10), p.2585-2594
Ort / Verlag
Weinheim: WILEY‐VCH Verlag
Erscheinungsjahr
2006
Quelle
Wiley-Blackwell Journals
Beschreibungen/Notizen
Virus‐specific CD4+ T cells with IL‐2‐secreting and/or proliferative capacity are detected readily in HIV‐1‐infected long‐term nonprogressors and rarely in persons with untreated progressive infection. The contribution of these cells to viraemia control is uncertain, but this question might be addressed in clinical therapeutic vaccination studies. However, the quality of T helper responses induced by currently available HIV‐1 vaccine candidates has not been explored in depth. We determined the effect of vaccination with modified vaccinia virus Ankara (MVA) expressing HIV‐1 gag p24/p17 (MVA.HIVA) on HIV‐1‐specific CD4+ T cell responses in 16 chronically infected, highly active antiretroviral therapy (HAART)‐treated subjects using CD8‐depleted IFN‐γ ELISPOT assays, intracellular cytokine staining assays for IL‐2 and IFN‐γ, and a CFSE‐based proliferation assay. Gag‐specific CD4+ T cell responses were significantly increased in magnitude and breadth after vaccination and targeted both known and new epitopes, several of which were also recognised by healthy HIV‐uninfected volunteers immunised with the same vaccines. The frequencies of CD4+ T cells expressing IL‐2 or IFN‐γ, alone or simultaneously, were also augmented. These findings indicate that functional virus‐specific T helper cells can be boosted by vaccination in chronic HIV‐1 infection. Further evaluation of their role in viraemia control is warranted.